Table 3.
Incidence of comorbid conditions in the study population.
| Number of High Risk Criteria | Number of Subjects n (%) |
|---|---|
| 1 | 42 (34.7%) |
| 2 | 45 (37.2%) |
| 3 | 24 (19.8%) |
| 4 | 6 (5.0%) |
| 5 | 3 (2.5%) |
| 6 |
1 (0.8%) |
| Comorbid Conditions |
Percentage of Subjects (%) |
| BMI (30–40 kg/m2) | 78.5 |
| Hypertension | 59.5 |
| Cardiovascular disease | 34.7 |
| Diabetes | 33.1 |
| COPD | 28.1 |
| Malignancy | 24.8 |
| Active smoker | 23.1 |
| Immunosuppression | 8.3 |
| Chronic corticosteroid use | 5.0 |
| Advanced age | 5.0 |
| Hypo-albuminemia | 2.5 |
| Renal insufficiency | 0.8 |